Company Overview and News
This copy is for your personal non-commercial use only. To order presentation-ready copies of Toronto Star content for distribution to colleagues, clients or customers, or inquire about permissions/licensing, please go to: www.TorontoStarReprints.com
It's been six months since I presented 4 hedged portfolios and 10 top names in week 33 of my Marketplace service (January 11th). Here's how everything did.
SQ TLYS AZO THO NFLX TECK DLTR URI IDTI IPGP NSP PENN NTAP TCKRF GDXJ ORLY
SHANGHAI/BEIJING (Reuters) - China’s sovereign wealth fund China Investment Corp (CIC) posted a 37.55 percent rise in 2017 net profit, boosted by record-high returns from its overseas portfolio.
CICHY 55BC TCKRF CBQS CICHF CCB TECK 0939
United States officials are accusing their Canadian counterparts of sitting on damning new data about toxic chemicals from southern British Columbia coal mines in water shared by both countries.
TCKRF BEAV TECK
HALIFAX, Nova Scotia, July 05, 2018 (GLOBE NEWSWIRE) -- Erdene Resource Development Corp. (TSX:ERD) ("Erdene" or "Company"), is pleased to report results for the third series of drill holes from its Q2-2018 drill program at its 100%-owned Bayan Khundii Gold Project (“Bayan Khundii”) in southwest Mongolia.
SAND SSL SDDXF SNXZF TCKRF ERDCF ERD TECK
Teck Resources (NYSE:TECK) should be considered to be a runner-up to the three commodity giants in the world. The company is indeed smaller than BHP Billiton (NYSE:BHP), Rio Tinto (NYSE:RIO) and Glencore (OTCPK:GLNCY, OTCPK:GLCNF), and is often overlooked by investors.
RIO RIO BLT BHPBF TECK RTPPF BHP RIO RTNTF BBL BHP TCKRF BHPLF
(Reuters) - Canada’s main stock index opened higher for the second straight session on Tuesday, helped by gains in shares of material and energy companies due to a rise in oil and gold prices.
TAHO HBM HBM.WS CVE THO CVE HBM TCKRF TECK
CALGARY, Alberta, June 28, 2018 (GLOBE NEWSWIRE) -- Copper Fox Metals Inc. (“Copper Fox” or the “Company”) (TSX-V:CUU) (OTC:CPFXF) is pleased to announce that its unaudited interim consolidated April 30, 2018 financial statements have been filed on SEDAR.
CXM CAXPF TCKRF CAXPD CPFXF TECK
Warintza and La Verde hold 3.7 billion pounds of copper in the measured and indicated category and another 4.6 billion pounds of copper in the inferred category.
ATHTF ABX NCA AOZ EQXGF LGC LWLCF TECK CTMQF GMN CCY CATXF TCKRF LGCUD LGCUF AFY JDL ABX
VANCOUVER, British Columbia, June 27, 2018 (GLOBE NEWSWIRE) -- NOVAGOLD RESOURCES INC. (NYSE American:NG) (TSX:NG) today released its 2018 second quarter financial results and updates for its flagship Donlin Gold project in Alaska, which NOVAGOLD owns equally with Barrick Gold Corporation (“Barrick”), and its Galore Creek copper-gold-silver project in British Columbia, which NOVAGOLD owns equally with Teck Resources Limited (“Teck”).
ABX NG MALRY MALRF TCKRF NG MIN ABX TECK
VANCOUVER, British Columbia, June 26, 2018 (GLOBE NEWSWIRE) -- Teck Resources Limited (TSX:TECK.A) (TSX:TECK.B) (NYSE:TECK) (“Teck”) will release its second quarter 2018 earnings results on Thursday, July 26, 2018 before market open.
DTK TCKRF TECK
HALIFAX, Nova Scotia, June 25, 2018 (GLOBE NEWSWIRE) -- Erdene Resource Development Corp. (TSX:ERD) ("Erdene" or "Company") announces the filing of an independent technical report in accordance with National Instrument 43-101 – Standards of Disclosure for Mineral Projects (“NI 43-101”) on its 100%-owned Altan Nar gold-polymetallic deposit (“Altan Nar”) in southwest Mongolia. The technical report, titled “Altan Nar Gold Project, Bayankhongor Aimag, Southwest Mongolia, National Instrument 43-101 Mineral Resource Technical Report” and dated June 21, 2018, (the “Altan Nar June 2018 Resource Report”) has been prepared by RPMGlobal (“RPM”), and is available on SEDAR (www.
SAND SSL SDDXF SNXZF TCKRF ERDCF ERD TECK
2018-07-13 - Asif
Overview Catabasis Pharmaceuticals is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of novel therapeutics based on its proprietary Safely Metabolized And Rationally Targeted linker, or SMART LinkerSM, drug discovery platform. The company's SMART Linker drug discovery platform enables it to engineer product candidates that can simultaneously modulate multiple targets in a disease. The company's proprietary product candidates impact pathways that are central to diseases where efficacy may be optimized by a multiple target approach. Catabasis Pharmaceuticals has applied its SMART Linker drug discovery platform to build an internal pipeline of product candidates for rare diseases, its primary focus, and plan to pursue partnerships to develop additional product candidates. The company's lead product candidate is edasalonexent, formerly known as CAT-1004, which the company believe has the potential to be a disease-modifying...
2018-07-09 - Asif
Overview Walmart Inc. helps people around the world save money and live better – anytime and anywhere – in retail stores and through eCommerce. Through innovation, Walmart is striving to create a customer-centric experience that seamlessly integrates its eCommerce and retail stores in an omni-channel offering that saves time for its customers. Each week, the company serve nearly 270 million customers who visit its more than 11,700 stores and numerous eCommerce websites under 65 banners in 28 countries. The company's strategy is to lead on price, invest to differentiate on access, be competitive on assortment and deliver a great experience. Leading on price is designed to earn the trust of its customers every day by providing a broad assortment of quality merchandise and services at everyday low prices ("EDLP"). EDLP is its pricing philosophy under which the company price items at a low price every day so its customers trust that its prices will not change under frequent prom...
2018-07-06 - Asif
Overview Nevro is a global medical device company focused on providing innovative products that improve the quality of life of patients suffering from chronic pain. Nevro has developed and commercialized the Senza® spinal cord stimulation (SCS) system, an evidence-based neuromodulation platform for the treatment of chronic pain. The company's proprietary paresthesia-free HF10TM therapy, delivered by its Senza system, was demonstrated in its SENZA-RCT study to be superior to traditional SCS therapy with it being nearly twice as successful in treating back pain and 1.5 times as successful in treating leg pain when compared to traditional SCS therapy. Comparatively, traditional SCS therapy has limited efficacy in treating back pain and is used primarily for treating leg pain, limiting its market adoption. The company's SENZA-RCT study, along with its European studies, represents what the company believe is the most robust body of clinical evidence for any SCS therapy. The compa...
as of ET